Atlas Trials

A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)

Clinical trial NCT05115019 · WITHDRAWN

Trial details

NCT number
NCT05115019
Sponsor
PT. Innovative Pharma Solutions
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2021-12-01
Primary completion
2022-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.